RV-positive | RV-A a | RV-B a | RV-C a | p-value | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Total (%) b | Single infection (%) | Co-infection (%) | Total (%) | Single infection (%) | Co-infection (%) | Total (%) | Total (%) | Single infection (%) | Co-infection (%) | RV-A vs. RV-C | |
URTI | 92 (17.5) | 64 (12.2) | 28 (5.3) | 45 (8.6) | 31 (5.9) | 14 (2.7) | 1 (0.2) | 27 (5.1) | 22 (4.2) | 5 (0.9) | 0.027 c |
Total samples (n=526) | |||||||||||
Age (months) | |||||||||||
≤12 (n=126) | 26 (20.6) | 18 (14.3) | 8 (6.3) | 12 (9.5) | 9 (7.1) | 3 (2.4) | 1 (0.8) | 7 (5.5) | 6 (4.8) | 1 (0.8) | 0.233 |
12-60 (n=248) | 30 (12.1) | 27 (10.9) | 13 (5.2) | 20 (8.1) | 12 (4.8) | 8 (3.2) | 0 | 14 (5.6) | 11 (4.4) | 3 (1.2) | 0.269 |
>60 (n=146) | 26 (17.8) | 19 (13.0) | 7 (4.8) | 13 (8.9) | 10 (6.8) | 3 (2.1) | 0 | 6 (4.1) | 5 (3.4) | 1 (0.7) | 0.096 |
LRTI | 62 (24.8) | 39 (15.6) | 23 (9.2) | 22 (8.0) | 15 (6.1) | 7 (2.8) | 3 (1.2) | 18 (7.2) | 12 (4.8) | 6 (2.4) | 0.509 |
Total samples (n=250) | |||||||||||
Age (months) | |||||||||||
≤12 (n=127) | 22 (17.3) | 12 (9.4) | 10 (7.9) | 9 (7.1) | 5 (3.9) | 4 (3.1) | 2 (1.6) | 4 (3.1) | 2 (1.6) | 2 (1.6) | 0.154 |
12-60 (n=105) | 33 (31.4) | 22 (20.9) | 11 (10.5) | 9 (8.6) | 6 (5.7) | 3 (2.9) | 1 (0.9) | 13 (12.4) | 9 (8.6) | 4(3.8) | 0.472 |
> 60 (n=2) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |